Meriwether Wealth & Planning’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-17,376
Closed -$837K 132
2026
Q1
$837K Buy
17,376
+1,293
+8% +$60.3K 0.46% 46
2025
Q4
$779K Buy
16,083
+1,726
+12% +$85.6K 0.44% 45
2025
Q3
$678K Buy
14,357
+407
+3% +$19.6K 0.39% 49
2025
Q2
$674K Sell
13,950
-239
-2% -$12.2K 0.42% 48
2025
Q1
$787K Buy
14,189
+2,017
+17% +$109K 0.51% 47
2024
Q4
$587K Buy
+12,172
New +$619K 0.42% 53

Other funds holding SNY

Meriwether Wealth & Planning's SNY Position: Q2 2026 in Review

Meriwether Wealth & Planning sold out of Sanofi (SNY) in Q2 2026, closing a stake of 17,376 shares — an estimated $837K sold.

Meriwether Wealth & Planning first reported a position in SNY in Q4 2024 and held it in 6 quarters. The position peaked at $837K in Q1 2026. 95 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Meriwether Wealth & Planning reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Meriwether Wealth & Planning sold 17,376 Sanofi shares in Q2 2026, an estimated $837K.
  • Meriwether Wealth & Planning first reported a position in Sanofi in Q4 2024 and held it in 6 quarters.
  • Meriwether Wealth & Planning's Sanofi position peaked at $837K in Q1 2026.
  • 95 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Meriwether Wealth & Planning's 13F filing for Q2 2026, filed 8 Jul 2026.